Resumes
Resumes
Technical Designer And Patternmaker
View pageWork:
Technical Designer and Patternmaker
Aiwen Li Phones & Addresses
-
660 Via Colinas, Westlake Village, CA 91362 (805) 230-3041
-
660 Via Colinas APT 342, Westlake Vlg, CA 91362 (805) 701-1640
-
Newbury Park, CA
-
114 Mountain View Ln, Clemson, SC 29631
-
2828 Egypt Rd, Norristown, PA 19403 (610) 631-5096
-
Eagleville, PA
-
Seneca, SC
-
Ventura, CA
Work
Position:
Technical designer and patternmaker
Technical Designer and Patternmaker
Publications
Us Patents
Thiazolyl Urea Compounds And Methods Of Uses
View pageUS Patent:
6645990, Nov 11, 2003
Filed:
Feb 15, 2002
Appl. No.:
10/077124
Inventors:
Benny C. Askew - Newbury Park CA
Frenel F. De Morin - Thousand Oaks CA
Andrew Hague - Camarillo CA
Ellen Laber - Ventura CA
Aiwen Li - Westlake Village CA
Gang Liu - Oak Park CA
Patricia Lopez - Northridge CA
Rana Nomak - Westlake Village CA
Vincent Santora - Ladera Ranch CA
Christopher Tegley - Thousand Oaks CA
Kevin Yang - San Gabriel CA
Frenel F. De Morin - Thousand Oaks CA
Andrew Hague - Camarillo CA
Ellen Laber - Ventura CA
Aiwen Li - Westlake Village CA
Gang Liu - Oak Park CA
Patricia Lopez - Northridge CA
Rana Nomak - Westlake Village CA
Vincent Santora - Ladera Ranch CA
Christopher Tegley - Thousand Oaks CA
Kevin Yang - San Gabriel CA
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07D21126
US Classification:
514342, 514241, 514247, 514256, 514315, 544162, 544180, 544182, 544224, 544333, 546229, 5462687
Abstract:
Selected novel urea compounds are effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving stoke, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Substituted Alkylamine Derivatives And Methods Of Use
View pageUS Patent:
6878714, Apr 12, 2005
Filed:
Jul 17, 2002
Appl. No.:
10/197974
Inventors:
Benny Askew - Newbury Park CA, US
Jeffrey Adams - Thousand Oaks CA, US
Shon Booker - Thousand Oaks CA, US
Guoqing Chen - Thousand Oaks CA, US
Lucian V. DiPietro - Gloucester MA, US
Daniel Elbaum - Newton MA, US
Julie Germain - Medford MA, US
Stephanie D. Geuns-Meyer - Medford MA, US
Gregory J. Habgood - Merrimac MA, US
Michael Handley - Greenbrae CA, US
Qi Huang - Moorpark CA, US
Aiwen Li - Westlake Village CA, US
Nobuko Nishimura - West Hills CA, US
Rana Nomak - Istanbul, TR
Vinod F. Patel - Acton MA, US
Babak Riahi - Woodland Hills CA, US
Joseph L. Kim - Wayland MA, US
Ning Xi - Thousand Oaks CA, US
Kevin Yang - San Gabriel CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Jeffrey Adams - Thousand Oaks CA, US
Shon Booker - Thousand Oaks CA, US
Guoqing Chen - Thousand Oaks CA, US
Lucian V. DiPietro - Gloucester MA, US
Daniel Elbaum - Newton MA, US
Julie Germain - Medford MA, US
Stephanie D. Geuns-Meyer - Medford MA, US
Gregory J. Habgood - Merrimac MA, US
Michael Handley - Greenbrae CA, US
Qi Huang - Moorpark CA, US
Aiwen Li - Westlake Village CA, US
Nobuko Nishimura - West Hills CA, US
Rana Nomak - Istanbul, TR
Vinod F. Patel - Acton MA, US
Babak Riahi - Woodland Hills CA, US
Joseph L. Kim - Wayland MA, US
Ning Xi - Thousand Oaks CA, US
Kevin Yang - San Gabriel CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K031/4427
C07D401/12
C07D401/12
US Classification:
514256, 514300, 514314, 514333, 514336, 514337, 544333, 546113, 546175, 546256, 546262, 5462717, 5462821, 5462827
Abstract:
Selected amines are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Substituted Arylamine Derivatives And Methods Of Use
View pageUS Patent:
7101868, Sep 5, 2006
Filed:
Apr 12, 2004
Appl. No.:
10/823809
Inventors:
Daniel Elbaum - Newton MA, US
Shon Booker - Thousand Oaks CA, US
Julie Germain - Medford MA, US
Gregory J. Habgood - Merrimac MA, US
Michael Handley - Greenbrae CA, US
Aiwen Li - Westlake Village CA, US
Nobuko Nishimura - West Hills CA, US
Vinod F. Patel - Acton MA, US
Chester Chenguang Yuan - Newbury Park CA, US
Joseph L. Kim - Wayland MA, US
Guolin Cai - Thousand Oaks CA, US
Guoqing Chen - Thousand Oaks CA, US
Michael Croghan - Thousand Oaks CA, US
Lucian V. Di Pietro - Wayland MA, US
Celia Dominguez - Thousand Oaks CA, US
Qi Huang - Moorpark CA, US
Andrew Tasker - Simi Valley CA, US
Ning Xi - Thousand Oaks CA, US
Shimin Xu - Ventura CA, US
Shon Booker - Thousand Oaks CA, US
Julie Germain - Medford MA, US
Gregory J. Habgood - Merrimac MA, US
Michael Handley - Greenbrae CA, US
Aiwen Li - Westlake Village CA, US
Nobuko Nishimura - West Hills CA, US
Vinod F. Patel - Acton MA, US
Chester Chenguang Yuan - Newbury Park CA, US
Joseph L. Kim - Wayland MA, US
Guolin Cai - Thousand Oaks CA, US
Guoqing Chen - Thousand Oaks CA, US
Michael Croghan - Thousand Oaks CA, US
Lucian V. Di Pietro - Wayland MA, US
Celia Dominguez - Thousand Oaks CA, US
Qi Huang - Moorpark CA, US
Andrew Tasker - Simi Valley CA, US
Ning Xi - Thousand Oaks CA, US
Shimin Xu - Ventura CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/33
A61K 31/44
C07D 211/62
C07D 213/72
A61K 31/44
C07D 211/62
C07D 213/72
US Classification:
514183, 514188, 514277, 514352, 514354, 514356, 546304, 546315, 546345
Abstract:
Selected compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Substituted Amine Derivatives And Methods Of Use
View pageUS Patent:
7102009, Sep 5, 2006
Filed:
Jul 17, 2002
Appl. No.:
10/197918
Inventors:
Vinod F. Patel - Acton MA, US
Benny Askew - Newbury Park CA, US
Shon Booker - Newbury Park CA, US
Guoqing Chen - Thousand Oaks CA, US
Lucian V. DiPietro - Gloucester MA, US
Julie Germain - Somerville MA, US
Gregory J. Habgood - Merrimac MA, US
Qi Huang - Moorpark CA, US
Aiwen Li - Westlake Village CA, US
Nobuko Nishimura - West Hills CA, US
Rana Nomak - Westlake Village CA, US
Babak Riahi - Woodland Hills CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Daniel Elbaum - Newton MA, US
Benny Askew - Newbury Park CA, US
Shon Booker - Newbury Park CA, US
Guoqing Chen - Thousand Oaks CA, US
Lucian V. DiPietro - Gloucester MA, US
Julie Germain - Somerville MA, US
Gregory J. Habgood - Merrimac MA, US
Qi Huang - Moorpark CA, US
Aiwen Li - Westlake Village CA, US
Nobuko Nishimura - West Hills CA, US
Rana Nomak - Westlake Village CA, US
Babak Riahi - Woodland Hills CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Daniel Elbaum - Newton MA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07D 401/02
A61K 31/44
A61K 31/44
US Classification:
5462771, 5462737, 5462757, 544253, 514255, 514338, 514339
Abstract:
Selected amines are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Thiazolyl Urea Compounds And Methods Of Uses
View pageUS Patent:
7196104, Mar 27, 2007
Filed:
Jul 30, 2003
Appl. No.:
10/631423
Inventors:
Frenel F. De Morin - Thousand Oaks CA, US
Andrew Hague - Camarillo CA, US
Ellen Laber - Ventura CA, US
Aiwen Li - Westlake Village CA, US
Gang Liu - Oak Park CA, US
Patricia Lopez - West Hills CA, US
Rana Nomak - Westlake Village CA, US
Vincent Santora - Carlsbad CA, US
Christopher Tegley - Thousand Oaks CA, US
Kevin Yang - San Gabriel CA, US
Andrew Hague - Camarillo CA, US
Ellen Laber - Ventura CA, US
Aiwen Li - Westlake Village CA, US
Gang Liu - Oak Park CA, US
Patricia Lopez - West Hills CA, US
Rana Nomak - Westlake Village CA, US
Vincent Santora - Carlsbad CA, US
Christopher Tegley - Thousand Oaks CA, US
Kevin Yang - San Gabriel CA, US
Assignee:
Amgen, Inc. - Thousand Oakes CA
International Classification:
A61K 31/44
C07D 417/12
C07D 417/12
US Classification:
514342, 514370, 5462697
Abstract:
Selected novel urea compounds are effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving stoke, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Inhibitors Of 11-Β-Hydroxy Steroid Dehydrogenase Type 1
View pageUS Patent:
7253196, Aug 7, 2007
Filed:
May 24, 2005
Appl. No.:
11/135662
Inventors:
Martin Henriksson - Uppsala, SE
Evert Homan - Sollentuna, SE
Lars Johansson - Stockholm, SE
Jerk Vallgarda - Uppsala, SE
Meredith Williams - Uppsala, SE
Eric A. Bercot - Moorpark CA, US
Christopher H. Fotsch - Thousand Oaks CA, US
Aiwen Li - Westlake Village CA, US
Guolin Cai - Thousand Oaks CA, US
Randall W. Hungate - Camarillo CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Christopher Tegley - Thousand Oaks CA, US
David J. St. Jean, Jr. - Camarillo CA, US
Nianhe Han - Thousand Oaks CA, US
Qi Huang - Moorpark CA, US
Qingyian Liu - Camarillo CA, US
Michael D. Bartberger - Sherman Oaks CA, US
George A. Moniz - Cambridge MA, US
Matthew J. Frizzle - Arlington MA, US
Evert Homan - Sollentuna, SE
Lars Johansson - Stockholm, SE
Jerk Vallgarda - Uppsala, SE
Meredith Williams - Uppsala, SE
Eric A. Bercot - Moorpark CA, US
Christopher H. Fotsch - Thousand Oaks CA, US
Aiwen Li - Westlake Village CA, US
Guolin Cai - Thousand Oaks CA, US
Randall W. Hungate - Camarillo CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Christopher Tegley - Thousand Oaks CA, US
David J. St. Jean, Jr. - Camarillo CA, US
Nianhe Han - Thousand Oaks CA, US
Qi Huang - Moorpark CA, US
Qingyian Liu - Camarillo CA, US
Michael D. Bartberger - Sherman Oaks CA, US
George A. Moniz - Cambridge MA, US
Matthew J. Frizzle - Arlington MA, US
Assignee:
Amgen, Inc. - Thousand Oaks CA
Biovitrum AB - Stockholm
Biovitrum AB - Stockholm
International Classification:
A61K 31/426
C07D 279/06
C07D 279/06
US Classification:
514369, 548182
Abstract:
The present invention relates to compounds with the formula (I), (II), (III) or (IV):.
Substituted Anthranilic Amide Derivatives And Methods Of Use
View pageUS Patent:
7307088, Dec 11, 2007
Filed:
Jul 8, 2003
Appl. No.:
10/615809
Inventors:
Qi Huang - Moorpark CA, US
Guoqing Chen - Thousand Oaks CA, US
Aiwen Li - Westlake Village CA, US
Babak Riahi - Woodland Hills CA, US
Andrew Tasker - Simi Valley CA, US
Kevin Yang - San Gabriel CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Guoqing Chen - Thousand Oaks CA, US
Aiwen Li - Westlake Village CA, US
Babak Riahi - Woodland Hills CA, US
Andrew Tasker - Simi Valley CA, US
Kevin Yang - San Gabriel CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/4709
A61K 31/4725
A61K 31/404
A61K 31/357
C07D 217/04
C07D 215/38
C07D 209/08
C07D 319/18
A61K 31/4725
A61K 31/404
A61K 31/357
C07D 217/04
C07D 215/38
C07D 209/08
C07D 319/18
US Classification:
514310, 514311, 514414, 514415, 514456, 546143, 546159, 548504, 549362
Abstract:
Selected compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Substituted 2,3-Dihydro-1H-Isoindol-1-One Derivatives And Methods Of Use
View pageUS Patent:
7320992, Jan 22, 2008
Filed:
Aug 24, 2004
Appl. No.:
10/926238
Inventors:
Christopher Tegley - Thousand Oaks CA, US
Jeffrey A. Adams - Thousand Oaks CA, US
Michael Croghan - Thousand Oaks CA, US
Daniel Elbaum - Newton MA, US
Julie Germain - Medford MA, US
Gregory J. Habgood - Merrimac MA, US
Scott Harried - Woodland Hills CA, US
Aiwen Li - Westlake Village CA, US
Nobuko Nishimura - West Hills CA, US
Rana Nomak - Istanbul, TR
Andrew Tasker - Simi Valley CA, US
Kevin Yang - San Gabriel CA, US
Jeffrey A. Adams - Thousand Oaks CA, US
Michael Croghan - Thousand Oaks CA, US
Daniel Elbaum - Newton MA, US
Julie Germain - Medford MA, US
Gregory J. Habgood - Merrimac MA, US
Scott Harried - Woodland Hills CA, US
Aiwen Li - Westlake Village CA, US
Nobuko Nishimura - West Hills CA, US
Rana Nomak - Istanbul, TR
Andrew Tasker - Simi Valley CA, US
Kevin Yang - San Gabriel CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/4439
C07D 401/12
C07D 401/12
US Classification:
514339, 5462771, 546152, 546139, 546113, 548472, 544111, 514416, 514314, 514307, 514300, 5142315
Abstract:
Selected compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.